Advertisement

PharmacoEconomics & Outcomes News

, Volume 308, Issue 1, pp 5–5 | Cite as

Low-dose IFN-α-2a good value in high-risk melanoma

Clinical study
  • 8 Downloads

Keywords

Melanoma Cost Effectiveness Survival Advantage American Joint Committee Primary Melanoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 2001

Personalised recommendations